Table 5.

Proportional hazard regression and time to death. Comparison between MHC class I products and HLA genotype

Strata	Factors	Univariate analysis			Multivariate analysis
		HR	95% CI	P	HR	95% CI	P
All patients not stratified	WP versus BP	3.3	2.2–4.9	<0.001	3.2	2.1–4.9	<0.001
	HC10 low versus high	1.7	1.1–2.5	0.01	1.14	0.65–1.99	0.64
	HCA low versus high	1.50	1.01–2.2	0.02	1.37	0.8–2.3	0.24
	L368 low versus high	1.27	0.86–1.9	0.22	0.79	0.49–1.3	0.34
HLA-A02*	WP versus BP	5.4	3–10	<0.001	5.8	3.1–10.9	<0.001
	HC10 low versus high	1.8	1–3.2	0.05	1.3	0.5–3.2	0.54
	HCA low versus high	1.5	0.9–2.6	0.1	0.9	0.4–2.3	0.99
	L368 low versus high	1.34	0.83–2.1	0.23	0.7	0.4–1.3	0.31